Key Points

The company unveiled its latest set of quarterly earnings. It showed robust growth, but a Department of Justice complaint is dogging its stock. 10 stocks we like better than SelectQuote ›

Veteran health insurance broker SelectQuote (NYSE: SLQT) wasn't quite looking like the wave of the future on Monday. The company's shares took a 12% hit on the day, following management's release of the latest set of quarterly figures. That was in rather sharp contrast to the overall stock market, where the benchmark S&P 500 index rose by a relatively steep 3.3%.

Healthy growth, but a bottom-line miss

For its fiscal third quarter of 2025, SelectQuote reaped just over $408 million in total revenue, up from the more than $376 million it earned in the same period of fiscal 2024. Generally accepted accounting principles (GAAP) net income came in at over $26 million ($0.03 per share), more than triple the under-$8.6 million profit of the year-ago period.Image source: Getty Images.

Although those increases were nothing to sneeze at, the company missed on the bottom line, if only slightly. On average, analysts tracking SelectQuote stock were modeling $0.04 per share net income. The company did beat on revenue, however, as the average pundit estimate was a bit over $402 million.

In its earnings release, SelectQuote quoted CEO Tim Danker as saying that "SelectQuote's agent-led model paired with our technology-enabled information advantage made our platform more valuable than ever to participants in the healthcare ecosystem."

Troubling accusations

However, investors might have been more concerned with what SelectQuote and its management team didn't say. In the earnings release, it didn't further address allegations brought by the government's Department of Justice (DoJ) in a complaint that the company -- along with peer health insurance brokers -- accepted illegal "kickback" payments by top insurers.

That, despite the fact that SelectQuote issued a press release Friday saying that it "strongly disagrees" with the allegations. It also vowed to defend itself against the DoJ's accusations, predicting a positive outcome for it in the case.

Should you invest $1,000 in SelectQuote right now?

Before you buy stock in SelectQuote, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and SelectQuote wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider whenNetflixmade this list on December 17, 2004... if you invested $1,000 at the time of our recommendation,you’d have $614,911!* Or when Nvidiamade this list on April 15, 2005... if you invested $1,000 at the time of our recommendation,you’d have $714,958!*

Now, it’s worth notingStock Advisor’s total average return is907% — a market-crushing outperformance compared to163%for the S&P 500. Don’t miss out on the latest top 10 list, available when you joinStock Advisor.

See the 10 stocks »

Story Continues

*Stock Advisor returns as of May 12, 2025

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Why SelectQuote Stock Got Slammed Today was originally published by The Motley Fool

View Comments